237 related articles for article (PubMed ID: 37194000)
41. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
[No Abstract] [Full Text] [Related]
42. Predictive value of red blood cell distribution width level on histological response and prognosis in colorectal liver metastases.
Chen Q; Chen J; Deng Y; Huang Z; Zhao H; Cai J
Ann Palliat Med; 2021 Sep; 10(9):9383-9397. PubMed ID: 34498473
[TBL] [Abstract][Full Text] [Related]
43. Changes in serum lactate dehydrogenase levels as markers of pathological response and prognosis in colorectal liver metastases patients receiving neoadjuvant chemotherapy followed by resection.
Chen J; Chen Q; Yao J; Jiang Y; Zhou J; Zhao H; Cai J
Ann Palliat Med; 2021 Oct; 10(10):10276-10292. PubMed ID: 34551571
[TBL] [Abstract][Full Text] [Related]
44. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.
Sugimoto K; Sakamoto K; Ii Y; Amemiya K; Sugo H; Ito T; Munakata S; Takahashi M; Kojima Y; Tomiki Y; Sato K; Saiura A; Kawasaki S
BMC Surg; 2021 Apr; 21(1):188. PubMed ID: 33836701
[TBL] [Abstract][Full Text] [Related]
45. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
[No Abstract] [Full Text] [Related]
46. Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
Margonis GA; Buettner S; Andreatos N; Sasaki K; Ijzermans JNM; van Vugt JLA; Pawlik TM; Choti MA; Cameron JL; He J; Wolfgang CL; Weiss MJ
Ann Surg; 2017 Oct; 266(4):641-649. PubMed ID: 28657938
[TBL] [Abstract][Full Text] [Related]
47. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
[TBL] [Abstract][Full Text] [Related]
48. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
[TBL] [Abstract][Full Text] [Related]
49. Nomograms predicting primary lymph node metastases and prognosis for synchronous colorectal liver metastasis with simultaneous resection of colorectal cancer and liver metastases.
Yao J; Chen Q; Deng Y; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
Ann Palliat Med; 2021 Apr; 10(4):4220-4231. PubMed ID: 33832313
[TBL] [Abstract][Full Text] [Related]
50. A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases.
Chun YJ; Kim SG; Lee KW; Cho SH; Kim TW; Baek JY; Park YS; Hong S; Chu CW; Beom SH; Jung M; Shin SJ; Ahn JB
Clin Colorectal Cancer; 2020 Sep; 19(3):e140-e150. PubMed ID: 32402681
[TBL] [Abstract][Full Text] [Related]
51. Development and validation of a nomogram to predict which patients with colorectal cancer liver metastases would benefit from primary tumor resection.
He M; Jia Z; Hu L; Wu H
Int J Colorectal Dis; 2023 May; 38(1):144. PubMed ID: 37237238
[TBL] [Abstract][Full Text] [Related]
52. Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.
Zhang Y; Wang Y; Yuan Y; Qiu J; Qiu Y; He W; Zheng Y; Wang Z; Gu Y; Lu Z; Chen G; Ding P; Wu X; Pan Z; Wan D; Li Y; Xu R; Yuan Y; Li B
World J Surg Oncol; 2020 May; 18(1):98. PubMed ID: 32423450
[TBL] [Abstract][Full Text] [Related]
53. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A
Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977
[TBL] [Abstract][Full Text] [Related]
54. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases.
Neal CP; Mann CD; Garcea G; Briggs CD; Dennison AR; Berry DP
Arch Surg; 2011 Apr; 146(4):471-8. PubMed ID: 21502458
[TBL] [Abstract][Full Text] [Related]
55. [Efficacy analysis on laparoscopic simultaneous resection of primary colorectal cancer and liver metastases].
Zhu DX; He GD; Mao YH; Wei Y; Ren L; Lin Q; Wang XY; Xu JM
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):584-588. PubMed ID: 32521979
[No Abstract] [Full Text] [Related]
56. Practice variation and outcomes of minimally invasive minor liver resections in patients with colorectal liver metastases: a population-based study.
de Graaff MR; Klaase JM; de Kleine R; Elfrink AKE; Swijnenburg RJ; M Zonderhuis B; D Mieog JS; Derksen WJM; Hagendoorn J; van den Boezem PB; Rijken AM; Gobardhan PD; Marsman HA; Liem MSL; Leclercq WKG; van Heek TNT; Pantijn GA; Bosscha K; Belt EJT; Vermaas M; Torrenga H; Manusama ER; van den Tol P; Oosterling SJ; den Dulk M; Grünhagen DJ; Kok NFM;
Surg Endosc; 2023 Aug; 37(8):5916-5930. PubMed ID: 37072639
[TBL] [Abstract][Full Text] [Related]
57. Long-Term Outcomes of Perioperative Versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases: An International Multicentre Propensity-Score Matched Analysis with Stratification by Contemporary Risk-Scoring.
Di Martino M; Primavesi F; Syn N; Dorcaratto D; de la Hoz Rodríguez Á; Dupré A; Piardi T; Rhaiem R; Blanco Fernández G; de Armas Conde N; Rodríguez Sanjuán JC; Fernández Santiago R; Fernández-Moreno MC; Ferret G; López Ben S; Suárez Muñoz MÁ; Perez-Alonso AJ; Koh YX; Jones R; Martín-Pérez E
Ann Surg Oncol; 2022 Oct; 29(11):6829-6842. PubMed ID: 35849284
[TBL] [Abstract][Full Text] [Related]
58. Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer.
Meng Y; Long C; Huang X; Huang L; Liao L; Tang W; Liu J
Bioengineered; 2021 Dec; 12(1):5138-5148. PubMed ID: 34436973
[TBL] [Abstract][Full Text] [Related]
59. Optimal Cut-Off Values of the Positive Lymph Node Ratio and the Number of Removed Nodes for Patients Receiving Resection of Bronchopulmonary Carcinoids: A Propensity Score-Weighted Analysis of the SEER Database.
Chen Q; Li M; Wang P; Chen J; Zhao H; Zhao J
Front Oncol; 2021; 11():696732. PubMed ID: 34367980
[TBL] [Abstract][Full Text] [Related]
60. Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases.
Akiyama T; Miyamoto Y; Imai K; Yamashita Y; Nomoto D; Daitoku N; Sakamoto Y; Kiyozumi Y; Tokunaga R; Eto K; Harada K; Hiyoshi Y; Iwatsuki M; Nagai Y; Iwagami S; Baba Y; Yoshida N; Baba H
Ann Surg Oncol; 2020 Sep; 27(9):3534-3541. PubMed ID: 32648180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
